Circadian and power spectral changes of RR and QT intervals during treatment of patients with angina pectoris with nadolol providing evidence for differential autonomic modulation of heart rate and ventricular repolarization

The American Journal of Cardiology

Volumn 74, Issue 2, 1994, Pages 131-136

  Sarma, Jonnalagedda S M ^a,b   Singh, Nalini ^a,b   Schoenbaum, Mary P ^a,b   Venkataraman, K ^a,b   Singh, Bramah N ^a,b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; NADOLOL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; ELECTROCARDIOGRAM; FOURIER TRANSFORMATION; HEART INNERVATION; HEART RATE; HEART REPOLARIZATION; HOLTER MONITORING; HUMAN; MALE; PRIORITY JOURNAL; QT INTERVAL; SPECTROSCOPY; ST SEGMENT; TREADMILL EXERCISE;

ANGINA PECTORIS; AUTONOMIC NERVOUS SYSTEM; CIRCADIAN RHYTHM; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FOURIER ANALYSIS; HEART RATE; HUMAN; MALE; MIDDLE AGE; MYOCARDIAL CONTRACTION; NADOLOL; REGRESSION ANALYSIS; SIGNAL PROCESSING, COMPUTER-ASSISTED; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; VAGUS NERVE; VENTRICULAR FUNCTION;

EID: 0028364774     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(94)90085-X     Document Type: Article

References (27)

1. Power spectral analysis as a clinical tool
2. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction
3. Power spectral analysis of heart rate variability in sudden cardiac death: comparison to other methods
4. Mechanistic and clinical aspects of acquired long QT syndromes
5. Acquired long QT syndrome due to antiarrhythmic drugs and bradyarrhythmias
6. Clinical aspects of the idiopathic long QT syndrome
7. Pathogenesis and therapy of the idiopathic long QT syndrome
8. Circadian rhythmicity of rate-corrected QT interval in hypothyroidism: significance for the development of class III antiarrhythmic agents
9. Prolongation of the Q-T interval in man during sleep
10. Long-term efficacy and safety of beta-adrenergic receptor antagonists for supraventricular tachycardia
11. Clinical pharmacology of the new beta adrenergic blocking drugs, part 9. Nadolol: a new long-acting beta-adrenoreceptor blocking drug
12. An exponential formula for heart rate dependence of QT interval during exercise and cardiac pacing in humans. Re-evaluation of Bazeti's formula
13. Relation between QT and RR intervals during exercise testing in atrial fibrillation
14. Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction
15. Clinical and research applications of ambulatory Holter ST-segment and heart rate monitoring
16. Effect of propranolol on the QT interval of normal individuals during exercise: a new method of studying interventions
17. Differential sensitivity of sinus node, atrioventricular node, atrium, and ventricle to propranolol
18. Mechanisms of regional ischemia and antianginal drug action during exercise
19. QT interval prolongation as predictor of sudden death in patients with myocardial infarction
20. Is QT interval prolongation a strong or weak predictor for cardiac death?
21. Assessment of autonomic function in humans by heart rate spectral analysis
22. Heart rate variability as an index of sympathovagal interaction after acute myocardial infarction
23. Time course of recovery of heart period variability after myocardial infarction
24. Effect of atenolol and diltiazem on heart period variability in normal persons
25. Accentuated antagonism between beta-adrenergic and vagal effects on ventricular refractoriness in humans
26. Effects of sympathetic and vagal nerves on the recovery properties of the endocardium and epicardium of the canine left ventricle